Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbinafine vs terbinafine + prednisolone for inflammatory tinea capitis (kerion)
IRCT20240225061105N1Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Nov 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Terbinafine and prednisolone in tinea capitis and kerion (2 arms), sponsored by Kermanshah University of Medical Sciences. Started Nov 2023; status: completed.
02
Drugs
Terbinafineprednisolone
03
Conditions
tinea capitiskerion
Beyond the preview
Go deeper on IRCT20240225061105N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240225061105N1.